IP Library Granted Patent US 8,557,999
Granted Patent B2
US 8,557,999 · App. 13/477,295 · Granted Oct 15, 2013

Pharmaceutical, dietary supplement, and food grade salts of anatabine

Inventors: Tom Thomas Puthiaparampil (Bangalore, IN); Thomas Kanathkunn David (Bangalore, IN); Muppala Sarveswara Raju (Bridgewater, NJ)
Assignee: Rock Creek Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,999
App. No.
13/477,295
Granted
Oct 15, 2013
Kind
B2
Abstract

Anatabine citrate and formulations containing anatabine citrate are useful for promoting health and well-being.

Claims (8)

1. Anatabine citrate.

2. A composition comprising a salt of claim 1 and an acceptable pharmaceutical, dietary supplement or food grade carrier, excipient, or diluent.

3. The composition of claim 2 which is a solid dosage form.

4. The composition of claim 3 further comprising at least one selected from the group consisting of sodium citrate, dicalcium phosphate, starches, lactose, sucrose, glucose, mannitol, silicic acid, carboxymethylcellulose, alginates, gelatin, polyvinylpyrrolidone, sucrose, acacia, glycerol, agaragar, calcium carbonate, potato or tapioca starch, alginic acid, silicates, sodium carbonate, paraffin, quaternary ammonium compounds, cetyl alcohol, glycerol monostearate, kaolin, bentonite clay, talc, calcium stearate, magnesium stearate, solid polyethylene glycols, and sodium lauryl sulfate.

5. A controlled release formulation comprising a salt of claim 1 and a biodegradable polymer.

6. The controlled release formulation of claim 5 wherein the biodegradable polymer is selected from the group consisting of poly(orthoesters), poly(anhydrides), and combinations thereof.

7. An extended release formulation comprising a salt of claim 1 and a swellable polymer.

8. The extended release formulation of claim 7 wherein the swellable polymer is selected from the group consisting of poly(ethylene oxide), hydroxypropyl methylcellulose, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2018
From: ROCK CREEK PHARMACEUTICALS, INC.
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 046780/0050 →
CHANGE OF NAME Recorded Jul 14, 2014
From: ROCK CREEK PHARMACEUTICALS, INC.
To: RCP DEVELOPMENT, INC.
Reel/Frame 033309/0825 →
Continuity (2)
Division 12729346 · Mar 23, 2010
Related Publication 20120232115A1 · Sep 13, 2012